Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

UNKNOWN × Stomach Neoplasms × raltitrexed × Clear all

Phase

Status

Sponsor Class

OTHER 2 UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1 Rectal Neoplasms 1

Interventions

S 1 (combination) 10 Oxaliplatin 5 titanium silicide 4 Surgical Procedures, Operative 2 Cisplatin 2 toripalimab 1 raltitrexed 1 pembrolizumab 1 nimotuzumab 1 Trastuzumab 1 Taxes 1 Radiotherapy, Intensity-Modulated 1 Paclitaxel 1 Irinotecan 1 Injections 1 Docetaxel 1 Chemotherapy, Adjuvant 1 Capecitabine 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03083613 2021-02-01

Raltitrexed and Paclitaxel for Gastric or Gastroesophageal Junction Adenocarcinoma

ChineseAMS

Phase 2 Completed

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡